MyBody-X angle on Mikrobiom Genetik

The combination of microbiome and genetics in consumer tests is an emerging field, but direct-to-consumer (DTC) products that claim to integrate both often lack solid scientific backing. While host genetics (e.g., lactase persistence, FTO variants) is well-studied, the microbiome is highly dynamic, influenced by diet, medications, and lifestyle. Many DTC tests extrapolate population-level associations to individuals without accounting for temporal variation or confounding factors. Evidence for actionable recommendations from combined microbiome-genetic tests is weak or mechanistic at best. No major clinical guidelines endorse such integrated tests for general health. Consumers should be cautious of personalized diet or supplement advice derived solely from these data. MyBody-X offers separate microbiome and DNA tests, but their combined interpretation requires clinical oversight. Without large, independent validation studies, the evidence remains mixed and largely marketing-driven.